HC
TMDX icon

Henshaw Capital’s Transmedics TMDX Stock Holding History

Henshaw Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,778
Closed -$536K – 259
2025
Q3 		$536K Sell
4,778
-2,665
-36% -$312K 0.02% 172
2025
Q2 		$997K Hold
7,443
– – 0.04% 150
2025
Q1 		$501K Buy
7,443
+1,189
+19% +$81.8K 0.02% 230
2024
Q4 		$390K Buy
6,254
+379
+6% +$35.3K 0.02% 255
2024
Q3 		$922K Hold
5,875
– – 0.04% 134
2024
Q2 		$885K Sell
5,875
-1,772
-23% -$213K 0.04% 125
2024
Q1 		$565K Hold
7,647
– – 0.03% 158
2023
Q4 		$604K Sell
7,647
-600
-7% -$36.2K 0.03% 148
2023
Q3 		$452K Buy
8,247
+3,071
+59% +$221K 0.03% 165
2023
Q2 		$435K Sell
5,176
-737
-12% -$56.4K 0.03% 133
2023
Q1 		$448K Sell
5,913
-1,173
-17% -$81.1K 0.03% 136
2022
Q4 		$437K Sell
7,086
-792
-10% -$42.1K 0.03% 131
2022
Q3 		$329K Hold
7,878
– – 0.02% 191
2022
Q2 		$248K Hold
7,878
– – 0.02% 255
2022
Q1 		$212K Buy
+7,878
New +$141K 0.01% 304
2021
Q4 		– Sell
-7,878
Closed -$261K – 344
2021
Q3 		$261K Buy
7,878
+1,815
+30% +$55.5K 0.02% 283
2021
Q2 		$201K Buy
+6,063
New +$168K 0.01% 340

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Henshaw Capital's TMDX Position: Q4 2025 in Review

Henshaw Capital sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 4,778 shares — an estimated $536K sold.

Henshaw Capital first reported a position in TMDX in Q2 2021 and held it in 17 quarters. The position peaked at $997K in Q2 2025. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Henshaw Capital reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Henshaw Capital sold 4,778 Transmedics shares in Q4 2025, an estimated $536K.
  • Henshaw Capital first reported a position in Transmedics in Q2 2021 and held it in 17 quarters.
  • Henshaw Capital's Transmedics position peaked at $997K in Q2 2025.
  • 429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Henshaw Capital's 13F filing for Q4 2025, filed 28 May 2026.